Global Bone Morphogenetic Protein (BMP) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Bone Morphogenetic Protein (BMP) market size was valued at US$ 723 million in 2024 and is forecast to a readjusted size of USD 1305 million by 2031 with a CAGR of 8.9% during review period.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.
This report is a detailed and comprehensive analysis for global Bone Morphogenetic Protein (BMP) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bone Morphogenetic Protein (BMP) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bone Morphogenetic Protein (BMP)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bone Morphogenetic Protein (BMP) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bone Morphogenetic Protein (BMP) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sponge Carrier
Hydroxyapatite Carrier
Market segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Major players covered
Medtronic
Jiuyuan Gene Engineering
Cellumed
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bone Morphogenetic Protein (BMP) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bone Morphogenetic Protein (BMP), with price, sales quantity, revenue, and global market share of Bone Morphogenetic Protein (BMP) from 2020 to 2025.
Chapter 3, the Bone Morphogenetic Protein (BMP) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bone Morphogenetic Protein (BMP) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bone Morphogenetic Protein (BMP) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bone Morphogenetic Protein (BMP).
Chapter 14 and 15, to describe Bone Morphogenetic Protein (BMP) sales channel, distributors, customers, research findings and conclusion.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global core manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering and Cellumed. The top three companies have a market share of about 99%. North America is the largest global market for Bone Morphogenetic Protein (BMP) with a market share of approximately 69%, followed by Asia Pacific and Europe with a market share of 19% and 9%, respectively. In terms of application, Spinal Fusion is the largest downstream segment, accounting for approximately 73% of the market.
This report is a detailed and comprehensive analysis for global Bone Morphogenetic Protein (BMP) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bone Morphogenetic Protein (BMP) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bone Morphogenetic Protein (BMP) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bone Morphogenetic Protein (BMP)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bone Morphogenetic Protein (BMP) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Jiuyuan Gene Engineering, Cellumed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bone Morphogenetic Protein (BMP) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sponge Carrier
Hydroxyapatite Carrier
Market segment by Application
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive
Major players covered
Medtronic
Jiuyuan Gene Engineering
Cellumed
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bone Morphogenetic Protein (BMP) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bone Morphogenetic Protein (BMP), with price, sales quantity, revenue, and global market share of Bone Morphogenetic Protein (BMP) from 2020 to 2025.
Chapter 3, the Bone Morphogenetic Protein (BMP) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bone Morphogenetic Protein (BMP) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bone Morphogenetic Protein (BMP) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bone Morphogenetic Protein (BMP).
Chapter 14 and 15, to describe Bone Morphogenetic Protein (BMP) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
70 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Bone Morphogenetic Protein (BMP) by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
